Cellectis (CLLS) Short term Debt (2015 - 2026)
Cellectis' (CLLS) quarterly Short term Debt came in at $8.9 million in Q1 2026, down 46.96% year-on-year from $16.8 million in Q1 2025, and down 14.88% quarter-over-quarter from $10.5 million in Q4 2025.
Cellectis (CLLS) Short term Debt (2015 - 2026) Analysis & Trends
Cellectis' Short term Debt history runs 12 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- On a quarterly basis, Short term Debt fell 46.96% year-over-year to $8.9 million in Q1 2026; TTM through Mar 2026 was $8.9 million, a 46.96% decrease from a year earlier, with the FY2025 full-year figure at $10.5 million, down 35.17% from the prior year.
- Short term Debt declined to $8.9 million in Q1 2026 per CLLS's latest filing, from $10.5 million in the prior quarter.
- Across five years, Short term Debt topped out at $18.2 million in Q3 2025 and bottomed at $5.1 million in Q3 2023.
- The 5-year median for Short term Debt is $8.9 million (2026), against an average of $9.7 million.
- Across the five-year window, Short term Debt slumped 58.85% in 2023 and soared 256.12% in 2025, its largest moves.
- Year by year, Short term Debt stood at $5.1 million in 2022, then grew by 3.95% to $5.3 million in 2023, then surged by 205.05% to $16.1 million in 2024, then sank by 35.17% to $10.5 million in 2025, then declined by 14.88% to $8.9 million in 2026.
- Per Business Quant, the three latest CLLS Short term Debt figures stand at $8.9 million (Q1 2026), $10.5 million (Q4 2025), and $18.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.90 Mn |
| Dec 31, 2025 | 10.46 Mn |
| Sep 30, 2025 | 18.24 Mn |
| Jun 30, 2025 | 18.23 Mn |
| Mar 31, 2025 | 16.79 Mn |
| Dec 31, 2024 | 16.13 Mn |
| Sep 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | 5.17 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Sep 30, 2022 | 10.38 Mn |
| Jun 30, 2022 | 11.31 Mn |
| Mar 31, 2022 | 12.61 Mn |
| Dec 31, 2021 | 2.35 Mn |
| Jun 30, 2020 | 3.78 Mn |
| Dec 31, 2019 | 1.07 Mn |